NVO
NVO · 高风险高回报 · High Risk Reward
诺和诺德（Novo Nordisk）曾是全球市值最高的欧洲企业，市值一度突破约6000亿美元。2025年，股价从约$82高位跌至约$36，跌幅超过55%——GLP-1竞争格局恶化、CagriSema三期数据不及预期、Ozempic与Wegovy在中国、巴西、加拿大专利到期、管理层大换血，一切利空在同一年密集爆发。 Novo Nordisk was once the European company with the highest market capitalization in the world, with its market cap once exceeding approximately $600 billion. In 2025, the stock price fell from a high